Published in N Engl J Med on March 11, 1982
The Nottingham Health Profile as a measure of quality of life following combined heart and lung transplantation. J Epidemiol Community Health (1988) 3.35
Referral for lung transplantation: experience of a Birmingham Adult Cystic Fibrosis Centre between 1987 and 1994. Thorax (1996) 1.54
The current state of lung transplantation. Thorax (1989) 1.43
Heart and lung transplantation in patients with end stage lung disease. Br Med J (Clin Res Ed) (1987) 1.37
Recommendations on the management of pulmonary hypertension in clinical practice. Heart (2001) 1.28
Human polymorphonuclear leukocyte interaction with cyclosporine A. Infect Immun (1984) 1.27
Early experience of heart-lung transplantation. Arch Dis Child (1989) 1.20
Pulmonary arterial hypertension. Orphanet J Rare Dis (2013) 1.18
Prostacyclin (epoprostenol) and heart-lung transplantation as treatments for severe pulmonary hypertension. Br Heart J (1993) 1.17
Impairment of pulmonary endothelium-dependent relaxation in patients with Eisenmenger's syndrome. Br J Pharmacol (1990) 1.10
Treatment of pulmonary hypertension secondary to connective tissue diseases. Thorax (1999) 1.08
Heart-lung transplantation for cystic fibrosis. 1: Assessment. Arch Dis Child (1991) 1.05
Effect of inhibitors of nitric oxide release and action on vascular tone in isolated lungs of pig, sheep, dog and man. J Physiol (1994) 1.05
The evolution of techniques and indications for lung transplantation. Ann Surg (1990) 1.04
Role of reactive oxygen species in reperfusion injury of the rabbit lung. J Clin Invest (1989) 1.01
Cardiopulmonary response to dynamic exercise after heart and combined heart-lung transplantation. Br Heart J (1989) 1.00
Fusarium infection in lung transplant patients: report of 6 cases and review of the literature. Medicine (Baltimore) (2011) 0.97
Bilateral sequential lung transplantation for end stage septic lung disease. Thorax (1995) 0.96
A decade of lung transplantation. Ann Surg (1993) 0.96
Lung transplantation: a decade of experience. Ann Surg (1999) 0.95
Cystic fibrosis. 5. The current state of lung transplantation for cystic fibrosis. Thorax (1991) 0.92
Chronic obstructive pulmonary disease. 10: Bullectomy, lung volume reduction surgery, and transplantation for patients with chronic obstructive pulmonary disease. Thorax (2003) 0.91
History of clinical transplantation. World J Surg (2000) 0.91
Paediatric lung transplantation: the agony and the ecstasy. Thorax (1994) 0.90
Clinical experience in the management of pulmonary opportunist infection and rejection in recipients of heart-lung transplants. Thorax (1988) 0.90
Historic landmarks in clinical transplantation: conclusions from the consensus conference at the University of California, Los Angeles. World J Surg (2000) 0.90
Precursor frequency of donor-specific lymphocytes recovered from canine lung transplants. Clin Exp Immunol (1986) 0.88
Right ventricular plasticity and functional imaging. Pulm Circ (2012) 0.87
Rejection of combined heart-lung transplants in rats. Function and pathology. Am J Pathol (1987) 0.86
Lung transplantation: an overview of candidacy and outcomes. Ochsner J (2014) 0.84
Effect of single lung transplantation on pulmonary hypertension in patients with end stage fibrosing lung disease. Br Heart J (1991) 0.83
Survival benefits of heart and lung transplantation. Ann Surg (1996) 0.82
Distribution and concentration of cyclosporin in human blood. J Clin Pathol (1984) 0.82
Influence on ICU course, outcome and costs for lung transplantation after implementation of the new Swiss transplantation law. Transplant Res (2014) 0.82
Origin and immunological hyporeactivity of canine alveolar lymphocytes. Immunology (1985) 0.81
Respiratory mechanics after heart-lung and bilateral lung transplantation. Thorax (1997) 0.80
Supporting future surgical innovation. Lung transplantation as a case study. Ann Surg (1993) 0.80
Heart-lung transplantation. J Thorac Dis (2014) 0.79
The direct and indirect action of inhaled agents on the lung and its circulation: lessons for clinical science. Environ Health Perspect (2001) 0.79
Combined heart-lung transplantation: a perspective on the past and the future. Pediatr Cardiol (2012) 0.79
Overview of clinical lung transplantation. Cold Spring Harb Perspect Med (2014) 0.79
The role of heart and lung transplantation in the treatment of cystic fibrosis. J R Soc Med (1989) 0.79
History of heart-lung transplantation. Lung (1990) 0.78
The pathology of heart and heart and lung transplantation--an update. J Clin Pathol (1991) 0.77
Heart transplantation in congenital heart disease: in whom to consider and when? J Transplant (2013) 0.77
Efficacy of rapamycin and FK 506 in prolonging rat hind limb allograft survival. Ann Surg (1994) 0.77
Urinary cGMP concentrations in severe primary pulmonary hypertension. Thorax (1998) 0.77
Progress in the understanding and management of pulmonary arterial hypertension. Glob Cardiol Sci Pract (2015) 0.77
Cystic fibrosis: lung transplantation. A new option--a new dilemma! J R Soc Med (1992) 0.76
Cyclosporin A-treated guinea pig responder cells secrete a genetically restricted factor that suppresses the mixed leukocyte reaction. J Clin Invest (1983) 0.76
Serial monitoring of exhaled nitric oxide in lung transplant recipients. J Heart Lung Transplant (2014) 0.76
Lung and heart-lung transplantation. Evolution and new applications. Ann Surg (1991) 0.76
[Consensus recommendations of the Pulmonary Arterial Hypertension Study Group of the Austrian Society of Lung Diseases and Tuberculosis]. Wien Klin Wochenschr (2003) 0.75
Anesthetic considerations during heart-lung transplantation in a patient with an unresectable pulmonary artery sarcoma. Korean J Anesthesiol (2012) 0.75
Clinical Outcomes of Heart-Lung Transplantation: Review of 10 Single-Center Consecutive Patients. Korean J Thorac Cardiovasc Surg (2016) 0.75
Pulmonary hypertension-"state of the art" management in 2012. Indian Heart J (2012) 0.75
Cardiopulmonary allotransplantation, a collective review: experimental progress and current clinical status. Tex Heart Inst J (1983) 0.75
The surgical anatomy of experimental and clinical thoracic organ transplantation. Tex Heart Inst J (2004) 0.75
Lung transplantation: recent developments and future challenges. Tex Heart Inst J (2012) 0.75
Lung transplantation for chronic obstructive pulmonary disease: an exercise in quality rather than quantity? Thorax (1999) 0.75
Transplantation. JAMA (1986) 0.75
Transplantation for chronic pulmonary disease: referral and outcome in Northern Ireland, 1986-1990. Ulster Med J (1995) 0.75
The donor lung: conservation of a precious resource. Thorax (1998) 0.75
Surgery of the airway: historic notes. J Thorac Dis (2016) 0.75
Heart-lung transplantation for end-stage respiratory disease in cystic fibrosis patients. J R Soc Med (1993) 0.75
Pulmonary hypertension: evolution of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. J Thorac Dis (2016) 0.75
A review of pulmonary arterial hypertension: Part 2: Current and expected treatments. Neth Heart J (2004) 0.75
Lung Transplantation and the Routine Use of Cardiopulmonary Bypass and Median Sternotomy: Experience at the Ochsner Multi-Organ Transplant Institute. Ochsner J (2017) 0.75
Current status of lung transplantation. West J Med (1997) 0.75
Ex vivo lung perfusion review of a revolutionary technology. Ann Transl Med (2017) 0.75
First successful heart-lung transplantation in Japan: report of a case. Surg Today (2013) 0.75
Severe pulmonary arterial hypertension: stratification of medical therapies, mechanical support, and lung transplantation. Heart Fail Rev (2016) 0.75
Graft damage after a single lung transplantation for pulmonary hypertension in a rat model. Surg Today (1997) 0.75
Heart-lung transplantation for cystic fibrosis. Eur J Pediatr (1992) 0.75
Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med (1982) 6.79
A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med (1995) 6.14
Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol (1987) 5.33
The biosynthesis of insulin and a probable precursor of insulin by a human islet cell adenoma. Proc Natl Acad Sci U S A (1967) 5.04
The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med (1992) 4.88
Management of acute aortic dissections. Ann Thorac Surg (1970) 3.66
Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA (1989) 2.87
Anthracycline cardiomyopathy monitored by morphologic changes. Cancer Treat Rep (1978) 2.63
Heart and combined heart-kidney transplantation in patients with concomitant renal insufficiency and end-stage heart failure. Am J Transplant (2013) 2.61
Prosthetic replacement of the aortic arch. J Thorac Cardiovasc Surg (1975) 2.43
The cardiac donor. Surg Gynecol Obstet (1971) 2.39
Infectious complications after cardiac transplantation in man. Ann Intern Med (1971) 2.37
Sensitivity and specificity of echocardiographic diagnosis of pericardial effusion. Circulation (1974) 2.28
Cardiac transplantation in perspective for the future. Survival, complications, rehabilitation, and cost. J Thorac Cardiovasc Surg (1982) 2.26
A human T lymphocyte differentiation marker defined by monoclonal antibodies that block E-rosette formation. J Immunol (1981) 2.20
The long-term follow-up of patients undergoing saphenous vein bypass surgery. Circulation (1974) 2.19
Some recent advances in cardiac pathology. Hum Pathol (1979) 2.17
Treatment of acute inflammatory myocarditis assisted by endomyocardial biopsy. Am J Cardiol (1980) 2.17
Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center. Clin Infect Dis (2001) 2.09
Arrhythmias and thromboembolic complications after the extracardiac Fontan operation. J Thorac Cardiovasc Surg (1998) 2.09
Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest (1992) 2.07
Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. J Am Coll Cardiol (1988) 2.06
Intracoronary ultrasound in cardiac transplant recipients. In vivo evidence of "angiographically silent" intimal thickening. Circulation (1992) 2.04
Nocardial infections in the immunocompromised host: A detailed study in a defined population. Rev Infect Dis (1981) 2.03
Mitral valve prolapse in one hundred presumably healthy young females. Circulation (1976) 2.02
Effect of intrathoracic pressure on left ventricular performance. N Engl J Med (1979) 2.01
Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression. Arthritis Rheum (2000) 2.01
Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients. Circulation (1975) 1.96
Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation. Chest (1984) 1.91
Multiple valve replacement with the fresh aortic homograft. J Thorac Cardiovasc Surg (1968) 1.90
Models of arthritis and the search for anti-arthritic drugs. Pharmacol Ther (1983) 1.90
Treatment of patients with aortic dissection presenting with peripheral vascular complications. Ann Surg (1990) 1.88
Idiopathic cardiomyopathy, age, and suppressor-cell dysfunction as risk determinants of lymphoma after cardiac transplantation. Lancet (1978) 1.87
Aortic root replacement. Risk factor analysis of a seventeen-year experience with 270 patients. J Thorac Cardiovasc Surg (1995) 1.86
Diagnosis of human cardiac allograft rejection by serial cardiac biopsy. J Thorac Cardiovasc Surg (1973) 1.82
Transesophageal echocardiography and its potential for esophageal damage. Anesthesiology (1990) 1.80
Proinsulin and the biosynthesis of insulin. Recent Prog Horm Res (1969) 1.78
Cardiac transplant atherosclerosis. Transplant Proc (1987) 1.74
Cardiac transplantation in man. 3. Surgical aspects. Am J Surg (1969) 1.72
Defective in vitro suppressor cell function in idiopathic congestive cardiomyopathy. Circulation (1979) 1.70
Clinical spectrum of anthracycline antibiotic cardiotoxicity. Cancer Treat Rep (1978) 1.68
Stroke following coronary artery bypass grafting: a ten-year study. Ann Thorac Surg (1985) 1.68
Transmission of retroviruses by transfusion of screened blood in patients undergoing cardiac surgery. N Engl J Med (1989) 1.67
Cardiac transplantation in man. VII. Cardiac allograft pathology. Circulation (1970) 1.65
Early anthracycline cardiotoxicity. Am J Med (1978) 1.63
Ebstein's anomaly appearing in the neonate. A new surgical approach. J Thorac Cardiovasc Surg (1991) 1.62
Determination of the amino acid sequence of the monkey, sheep, and dog proinsulin C-peptides by a semi-micro Edman degradation procedure. J Biol Chem (1972) 1.62
Port-access coronary artery bypass grafting: a proposed surgical method. J Thorac Cardiovasc Surg (1996) 1.61
Primary cardiac neoplasms. Early and late results of surgical treatment in 42 patients. J Thorac Cardiovasc Surg (1987) 1.60
Risk factors for the development of obliterative bronchiolitis after lung transplantation. J Heart Lung Transplant (1996) 1.60
Cardiac papillary fibroelastoma and stroke. Echocardiographic diagnosis and guide to excision. Am J Med (1986) 1.59
Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro. Proc Natl Acad Sci U S A (1990) 1.59
Incidence and severity of transplant coronary artery disease early and up to 15 years after transplantation as detected by intravascular ultrasound. J Am Coll Cardiol (1995) 1.58
Long-term survivors of pediatric heart transplantation: a multicenter report of sixty-eight children who have survived longer than five years. J Pediatr (1997) 1.57
Operative treatment of aortic dissections. Experience with 125 patients over a sixteen-year period. J Thorac Cardiovasc Surg (1979) 1.57
Twenty-year survivors of heart transplantation at Stanford University. Am J Transplant (2008) 1.57
Valvular disease in the elderly: influence on surgical results. Ann Thorac Surg (1993) 1.55
A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients. N Engl J Med (1993) 1.54
Heart retransplantation: the 25-year experience at a single institution. J Heart Lung Transplant (1996) 1.54
Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study. Circulation (1999) 1.52
Endocardial infiltrates in human heart transplants: a serial biopsy analysis comparing four immunosuppression protocols. Hum Pathol (1990) 1.50
New technique for treatment of unstable distal femur fractures by locked double-plating: case report and biomechanical evaluation. J Trauma (2000) 1.50
Valve replacement in active bacterial endocarditis. N Engl J Med (1967) 1.50
Evaluation of heart-lung transplant recipients with prospective, serial transbronchial biopsies and pulmonary function studies. J Thorac Cardiovasc Surg (1989) 1.49